Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

4 clinical studies listed.

Filters:

Cancers

Tundra lists 4 Cancers clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT07292038

Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors

This study is to assess the MTD and PK of NM6603 in adult patients with advanced solid tumors.

Gender: All

Ages: 18 Years - 75 Years

Updated: 2026-01-14

3 states

Cancers
RECRUITING

NCT06046066

A Phase 1 Study of NM6603 in Advanced Solid Tumors

This study is to assess the MTD and RP2D of NM6603 in adult patients with advanced solid tumors.

Gender: All

Ages: 18 Years - Any

Updated: 2025-06-12

4 states

Cancers
RECRUITING

NCT05299710

Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)

The purpose of this study is to safely remove ovarian tissue in pre-pubertal pediatric patients, who are at risk for infertility from their medical treatment, for freezing for future restoration of fertility and hormone function.

Gender: FEMALE

Ages: Any - 11 Years

Updated: 2024-11-18

1 state

Cancers
NOT YET RECRUITING

NCT06416267

Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)

The aim of this proposal is to identify immune biomarkers, genetic risk, and the clinical consequences of low count monoclonal B-cell lymphocytosis (LC MBL), a common premalignant condition affecting up to 17% of European adults age\>40. LC MBL is a precursor to chronic lymphocytic leukemia (CLL), characterized by a circulating population of clonal B-cells. It is relatively understudied, despite emerging evidence of clinical consequences such as increased risk for life-threatening infections and lymphoid malignancies. Studies reported that male sex, age, family history of CLL, and CLL-susceptibility genetic loci were associated with LC MBL risk. These findings were reported in European ancestry individuals and have not been generalized to other thnicities. This study will provide this missing knowledge using a unique multi-ethnic Israeli population of Jews and Arabs that have one of the highest and lowest age-standardized incidence rates of CLL in the world, respectively, and characterized with different genetic backgrounds.

Gender: All

Ages: 40 Years - Any

Updated: 2024-05-16

Monoclonal B-Cell Lymphocytosis
Chronic Lymphocytic Leukemia
Infections
+6